Clinical Trials in San Francisco

Showing 3761-3780 of 12,991 trials

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

NCT04276935

This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.

High Grade Anal Canal Squamous Intraepithelial NeoplasiaHuman Immunodeficiency Virus

AIDS Malignancy Consortium20 participantsStarted Nov 2018

San Francisco, California, United States • Miami, Florida, United States • Chicago, Illinois, United States +1 more locations

COMPLETED< 1 mile

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04950712

The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.

Herpes Genitalis

GlaxoSmithKline537 participantsStarted Jun 2021

Long Beach, California, United States • Los Angeles, California, United States • San Francisco, California, United States +48 more locations

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Find Trials by Condition in San Francisco

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

MGD019 DART® Protein in Unresectable/Metastatic Cancer

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder